9-13168409-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378778.1(MPDZ):c.3211C>T(p.Arg1071*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000744 in 1,613,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000072 ( 0 hom. )
Consequence
MPDZ
NM_001378778.1 stop_gained
NM_001378778.1 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 4.42
Genes affected
MPDZ (HGNC:7208): (multiple PDZ domain crumbs cell polarity complex component) The protein encoded by this gene has multiple PDZ domains, which are hallmarks of protein-protein interactions. The encoded protein is known to interact with the HTR2C receptor and may cause it to clump at the cell surface. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-13168409-G-A is Pathogenic according to our data. Variant chr9-13168409-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 548149.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPDZ | NM_001378778.1 | c.3211C>T | p.Arg1071* | stop_gained | 22/47 | ENST00000319217.12 | NP_001365707.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPDZ | ENST00000319217.12 | c.3211C>T | p.Arg1071* | stop_gained | 22/47 | 5 | NM_001378778.1 | ENSP00000320006.7 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152056Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
15
AN:
152056
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 248792Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 134968
GnomAD3 exomes
AF:
AC:
7
AN:
248792
Hom.:
AF XY:
AC XY:
4
AN XY:
134968
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000719 AC: 105AN: 1461258Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 726930
GnomAD4 exome
AF:
AC:
105
AN:
1461258
Hom.:
Cov.:
31
AF XY:
AC XY:
44
AN XY:
726930
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74258
GnomAD4 genome
AF:
AC:
15
AN:
152056
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74258
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hydrocephalus, nonsyndromic, autosomal recessive 2 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 10, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 10, 2024 | Variant summary: MPDZ c.3211C>T (p.Arg1071X) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 2.8e-05 in 248792 control chromosomes (gnomAD). c.3211C>T has been reported in the literature in an individual affected with Hydrocephalus, foveal dysplasia, pulmonary abnormalities, and sensorineural hearing loss (Shaheen_2017). The following publication has been ascertained in the context of this evaluation (PMID: 28556411). ClinVar contains an entry for this variant (Variation ID: 548149). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | This sequence change creates a premature translational stop signal (p.Arg1071*) in the MPDZ gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MPDZ are known to be pathogenic (PMID: 23240096, 28556411). This variant is present in population databases (rs376078512, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with MPDZ-related conditions (PMID: 28556411). ClinVar contains an entry for this variant (Variation ID: 548149). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at